Shanrong Biotechnology Corp.
SRBT · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.049 | -0.034 | -0.16 | 0 |
| % Growth | -43.5% | 78.9% | – | – |
| Operating Cash Flow | – | – | -$0 | – |
| Capital Expenditures | – | – | $0 | – |
| Free Cash Flow | – | – | -$0 | – |